|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.720 -0.010 (-1.370%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 628 | 15.654% | 543 | 944 | 495,717 | 222,367 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 25,998 |
| Intangible Assets | 0 | -- | 0 | 195 | 158,985 | 160,835 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 312,960 | 277,013 | 277,936 |
| Other Non-current Assets | 331,358 | 4.415% | 317,347 | 2,746 | 569 | 521 |
| 331,986 | 4.434% | 317,890 | 316,845 | 932,284 | 687,657 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 401 | 138.690% | 168 | 0 | 10,318 | 32,005 | |
| Trade Receivables | 1,796 | -- | 0 | 10,052 | 33,666 | 12,452 | |
| Cash & Bank Balances | 7,221 | -24.961% | 9,623 | 1,520 | 5,931 | 9,443 | |
| Other Current Assets | 5,944 | -7.038% | 6,394 | 705 | 23,519 | 33,803 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 180,000 | |
| 15,362 | -5.085% | 16,185 | 12,277 | 73,434 | 267,703 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 2,661 | 434.337% | 498 | 974 | 8,477 | 44,630 | ||
| S-T Debt & Leases | 316,613 | -13.925% | 367,836 | 341,342 | 825,991 | 618,430 | ||
| Other Current Liabilities | 301,822 | -15.392% | 356,731 | 322,771 | 335,225 | 232,913 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 621,096 | -14.339% | 725,065 | 665,087 | 1,169,693 | 895,973 | |||
| Net Current Assets | (605,734) | -14.551% | (708,880) | (652,810) | (1,096,259) | (628,270) | ||
| Total Assets Less Current Liabilities | (273,748) | -29.986% | (390,990) | (335,965) | (163,975) | 59,387 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 85 | -98.953% | 8,118 | 3,600 | 463 | 213,680 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 0 | 77,220 | 57,082 | |||
| 85 | -98.953% | 8,118 | 3,600 | 77,683 | 270,762 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 4 | 300.000% | 1 | 1 | 1 | 1 | ||||
| Reserves | (273,623) | -31.442% | (399,109) | (339,566) | (241,659) | (211,376) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | (273,619) | -31.442% | (399,108) | (339,565) | (241,658) | (211,375) | ||||
| Non-controlling Interests | (214) | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| (273,833) | -31.389% | (399,108) | (339,565) | (241,658) | (211,375) | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 1,440 | 20,000 | 20,000 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -26,041 |
| %Change | -51.195% |
| EPS / (LPS) | RMB -0.042 |
| NBV Per Share (¥) | RMB -0.406 |